An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma

Treatment with Melphalan/HDS shows clinically meaningful efficacy and demonstrates a favorable benefit-risk profile in patients with unresectable mUM as compared to BAC.

Authors

Institutions

Publication Details

Journal
Annals of Surgical Oncology
Published
2025-04-07
DOI
https://doi.org/10.1245/s10434-025-17231-x
Citations
7
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
11.95
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma

Carsten Weishaupt, Erika Richtig, Ana Arance, Anja Gesierich et al.
7 citations
Annals of Surgical Oncology
Ocular Oncology and Treatments
11.95
article

An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma

Carsten Weishaupt, Erika Richtig, Ana Arance, Anja Gesierich, Armin Bender, Jonathan S. Zager, Pier Francesco Ferrucci, Sebastian Haferkamp, Michel Rivoire, Sebastian Ochsenreither, Marlana Orloff, Michael Lowe, Matthew Wheater, David J. Eschelman, John Harrison Howard, Georgia M. Beasley, Martin Gschnell, Aslam M. Ejaz, Christian H. Ottensmeier, Joseph J. Sacco, Stephen W. Fenwick, Evan S. Glazer, Reinhard Dummer, Johnny John, Sunil Reddy, Junsung Choi
article en
7 citations

Abstract

Treatment with Melphalan/HDS shows clinically meaningful efficacy and demonstrates a favorable benefit-risk profile in patients with unresectable mUM as compared to BAC.

Annals of Surgical OncologyVol. 32(7)
University of Liverpool (GB), Thomas Jefferson University (US), Emory University (US), University of Tennessee Health Science Center (US), Philipps University of Marburg (DE), Duke University (US), Medical University of Graz (AT), University of South Florida (US), Aintree University Hospitals NHS Foundation Trust (GB), University Hospital Southampton NHS Foundation Trust (GB), Clatterbridge Cancer Centre NHS Foundation Trust (GB), Moffitt Cancer Center (US), University Hospital Regensburg (DE), University Hospital of Zurich (CH), University Hospital Münster (DE), Centre Léon Bérard (FR), Hospital Clínic de Barcelona (ES), Delcath Systems (United States) (US), Universitätsklinikum Würzburg (DE), The Ohio State University (US), European Institute of Oncology (IT), Charité - Universitätsmedizin Berlin (DE), University of South Alabama (US), Stanford University (US)
Good health and well-being
Openalex Percentile: Top 1%
Ocular Oncology and Treatments
11.95
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.